(Verbatim from the Applicant): We have developed and characterized an in vitro culture system that facilitates the chondrogenic differentiation of mammalian mesenchymal progenitor cells. We now propose to use the system to explore the stage of chondrogenesis involving progression from condensation to expression of cartilage extracellular matrix molecules. Recent evidence suggests a role for the MAP kinase pathways in controlling progression. Furthermore, the effects of p38 MAPK are similar to those seen with Wnt/beta-catenin signaling during chondrogenesis. Wnt pathways may be linked to the MAP kinases, and these combine to regulate progression. Wnts are a family of secreted proteins that appear to have important roles in development. Wnt involvement in chondrogenesis has been implied but it is unclear which Wnts are important. Modulation of Wnt action by Frzbs, the Wnt binding proteins, may be another level of control for chondrogenic progression. The overall hypothesis is that a specific, coordinated and temporal regulation of condensation-related proteins is necessary for progression from condensation to matrix production during chondrogenesis.
The Specific Aims to test this hypothesis are: (1) to characterize ERK 1/2 and p38 MAPK signaling during progression; (2) to characterize the Wnt pathways that operate during progression; and (3) to determine the role of Frzb, the Wnt binding protein expressed during chondrogenesis. This work will further our understanding of chondrogenic differentiation from progenitor cells. This may be of benefit for designing new therapeutic strategies for cartilage-related problems.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR044390-06
Application #
6497366
Study Section
Orthopedics and Musculoskeletal Study Section (ORTH)
Program Officer
Tyree, Bernadette
Project Start
1996-12-15
Project End
2005-01-31
Budget Start
2002-02-01
Budget End
2003-01-31
Support Year
6
Fiscal Year
2002
Total Cost
$254,363
Indirect Cost
Name
Case Western Reserve University
Department
Orthopedics
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Markway, Brandon D; Cho, Holly; Zilberman-Rudenko, Jevgenia et al. (2015) Hypoxia-inducible factor 3-alpha expression is associated with the stable chondrocyte phenotype. J Orthop Res 33:1561-70
McAlinden, Audrey; Johnstone, Brian; Kollar, John et al. (2008) Expression of two novel alternatively spliced COL2A1 isoforms during chondrocyte differentiation. Matrix Biol 27:254-66
Sun, Yulong; Berger, Evelyn J; Zhao, Chunfeng et al. (2006) Expression and mapping of lubricin in canine flexor tendon. J Orthop Res 24:1861-8
Huang, Jerry I; Kazmi, Najam; Durbhakula, Mahidhar M et al. (2005) Chondrogenic potential of progenitor cells derived from human bone marrow and adipose tissue: a patient-matched comparison. J Orthop Res 23:1383-9
Hering, Thomas M; Kazmi, Najam H; Huynh, Tru D et al. (2004) Characterization and chondrocyte differentiation stage-specific expression of KRAB zinc-finger protein gene ZNF470. Exp Cell Res 299:137-47
Hanada, K; Solchaga, L A; Caplan, A I et al. (2001) BMP-2 induction and TGF-beta 1 modulation of rat periosteal cell chondrogenesis. J Cell Biochem 81:284-94
Angele, P; Kujat, R; Nerlich, M et al. (1999) Engineering of osteochondral tissue with bone marrow mesenchymal progenitor cells in a derivatized hyaluronan-gelatin composite sponge. Tissue Eng 5:545-54
Johnstone, B; Hering, T M; Caplan, A I et al. (1998) In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 238:265-72
Yoo, J U; Barthel, T S; Nishimura, K et al. (1998) The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am 80:1745-57